China Health Industries Holdings(CHHE)
$0.200.00 (0.00%)
CHHE
China Health Industries Holdings financials statements
$0.20
At close:0.00 (0.00%)
China Health Industries Holdings (CHHE) Ratios
8 Followers
China Health Industries Holdings Ratios
CHHE's free cash flow for Q3 2024 was $3.34K. For the 2024 fiscal year, CHHE's free cash flow was increased by $0.00 and operating cash flow was $3.34K. See a summary of the company’s cash flow.
| Ratios | Jun 23 | Jun 22 | Jun 21 | Jun 20 | Jun 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 6.86 | 5.74 | 5.24 | 4.88 | 4.48 |
| Quick Ratio | 6.85 | 5.67 | 5.15 | 4.78 | 4.38 |
| Cash Ratio | 0.01 | 5.64 | 4.87 | 4.21 | 4.14 |
| Solvency Ratio | 0.05 | 0.06 | 0.24 | 0.51 | 0.48 |
| Operating Cash Flow Ratio | -7.08 | 0.27 | 0.61 | 0.28 | 0.60 |
| Short-Term Operating Cash Flow Coverage | -8.20 | 0.31 | 0.69 | 0.33 | 0.73 |
| Net Current Asset Value | $ 35.00M | $ 37.65M | $ 38.62M | $ 33.22M | $ 29.83M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.11 | 0.13 | 0.15 | 0.15 | 0.15 |
| Debt-to-Equity Ratio | 0.13 | 0.16 | 0.18 | 0.18 | 0.19 |
| Debt-to-Capital Ratio | 0.12 | 0.14 | 0.15 | 0.15 | 0.16 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.15 | 1.19 | 1.20 | 1.22 | 1.23 |
| Debt Service Coverage Ratio | -0.22 | -0.12 | 0.27 | 0.60 | 0.59 |
| Interest Coverage Ratio | -3194.11 | -2357.65 | 2383.63 | 6138.02 | 4055.11 |
| Debt to Market Cap | 0.52 | 10.31 | 0.62 | 0.32 | 0.14 |
| Interest Debt Per Share | 0.08 | 0.10 | 0.12 | 0.11 | 0.11 |
| Net Debt to EBITDA | -4.42 | 46.55 | -12.50 | -4.95 | -5.18 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.20% | -554.68% | 56.09% | 73.25% | 75.87% |
| EBIT Margin | -1651.74% | -617228.46% | 31.14% | 50.52% | 50.58% |
| EBITDA Margin | -1036.04% | -305992.51% | 44.68% | 58.63% | 59.39% |
| Operating Profit Margin | -1651.74% | -617228.46% | 28.71% | 49.25% | 49.19% |
| Pretax Profit Margin | -366.56% | -131460.67% | 31.14% | 50.51% | 50.58% |
| Net Profit Margin | -366.56% | -132584.27% | 19.88% | 35.75% | 35.65% |
| Continuous Operations Profit Margin | -366.56% | -132584.27% | 19.88% | 35.75% | 35.65% |
| Net Income Per EBT | 100.00% | 100.85% | 63.85% | 70.78% | 70.50% |
| EBT Per EBIT | 22.19% | 21.30% | 108.48% | 102.56% | 102.83% |
| Return on Assets (ROA) | -0.91% | -0.70% | 2.40% | 7.36% | 7.23% |
| Return on Equity (ROE) | -1.05% | -0.83% | 2.88% | 8.95% | 8.89% |
| Return on Capital Employed (ROCE) | -4.71% | -3.85% | 4.16% | 12.33% | 12.27% |
| Return on Invested Capital (ROIC) | -4.16% | -3.33% | 2.25% | 7.38% | 7.29% |
| Return on Tangible Assets | -0.93% | -0.72% | 2.49% | 7.72% | 7.70% |
| Earnings Yield | -4.16% | -54.01% | 9.85% | 15.48% | 6.73% |
| Efficiency Ratios | |||||
| Receivables Turnover | 58.08 | 0.01 | 2.73 | 2.13 | 4.60 |
| Payables Turnover | 0.39 | 0.01 | 7.01 | 6.54 | 4.50 |
| Inventory Turnover | 2.74 | 0.00 | 3.74 | 3.29 | 2.61 |
| Fixed Asset Turnover | 0.04 | 0.00 | 1.55 | 2.37 | 2.04 |
| Asset Turnover | 0.00 | 0.00 | 0.12 | 0.21 | 0.20 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.18 | 0.32 | 0.33 |
| Cash Conversion Cycle | -800.99 | 95412.66 | 179.20 | 226.51 | 138.07 |
| Days of Sales Outstanding | 6.28 | 56520.32 | 133.77 | 171.41 | 79.33 |
| Days of Inventory Outstanding | 133.10 | 108837.86 | 97.51 | 110.91 | 139.81 |
| Days of Payables Outstanding | 940.38 | 69945.53 | 52.08 | 55.80 | 81.07 |
| Operating Cycle | 139.38 | 165358.18 | 231.28 | 282.31 | 219.14 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.64 | 0.03 | 0.08 | 0.04 | 0.08 |
| Free Cash Flow Per Share | -0.64 | 0.03 | 0.08 | 0.03 | 0.08 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 528931.73 | 406.93 | 15.24 | 33.31 |
| Capital Expenditure Coverage Ratio | 0.00 | 528931.73 | 406.93 | 15.24 | 33.31 |
| Operating Cash Flow Coverage Ratio | -8.20 | 0.31 | 0.69 | 0.33 | 0.73 |
| Operating Cash Flow to Sales Ratio | -378.86 | 7924.07 | 0.86 | 0.24 | 0.55 |
| Free Cash Flow Yield | -429.99% | 322.81% | 42.29% | 9.80% | 10.09% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -24.04 | -1.85 | 10.15 | 6.46 | 14.86 |
| Price-to-Sales (P/S) Ratio | 88.11 | 2454.68 | 2.02 | 2.31 | 5.30 |
| Price-to-Book (P/B) Ratio | 0.25 | 0.02 | 0.29 | 0.58 | 1.32 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.23 | 0.31 | 2.36 | 10.21 | 9.91 |
| Price-to-Operating Cash Flow Ratio | -0.23 | 0.31 | 2.36 | 9.54 | 9.61 |
| Price-to-Earnings Growth (PEG) Ratio | -1.62 | 0.01 | -0.16 | 0.88 | -0.01 |
| Enterprise Value Multiple | -12.92 | 45.75 | -7.98 | -1.01 | 3.74 |
| Enterprise Value | 14.94M | -37.37M | -23.16M | -5.87M | 20.61M |
| EV to EBITDA | -12.92 | 45.75 | -7.98 | -1.01 | 3.74 |
| EV to Sales | 133.88 | -139980.67 | -3.57 | -0.59 | 2.22 |
| EV to Free Cash Flow | -0.35 | -17.67 | -4.18 | -2.61 | 4.15 |
| EV to Operating Cash Flow | -0.35 | -17.67 | -4.17 | -2.44 | 4.03 |
| Tangible Book Value Per Share | 0.58 | 0.63 | 0.65 | 0.57 | 0.52 |
| Shareholders’ Equity Per Share | 0.60 | 0.65 | 0.68 | 0.61 | 0.57 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.01 | 0.36 | 0.29 | 0.30 |
| Revenue Per Share | 0.00 | 0.00 | 0.10 | 0.15 | 0.14 |
| Net Income Per Share | -0.01 | -0.01 | 0.02 | 0.05 | 0.05 |
| Tax Burden | 1.00 | 1.01 | 0.64 | 0.71 | 0.70 |
| Interest Burden | 0.22 | 0.21 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 103.41 | -5.98 | 4.30 | 0.68 | 1.55 |
Currency in USD
